中新网上海1月9日电（记者 陈静）三阴性乳腺癌因其恶性程度高、容易复发转移、治疗手段单一、缺乏有效治疗靶点，素有“最毒乳腺癌”之称。记者9日获悉，一项针对转移性三阴性乳腺癌一线治疗的临床研究表明，采用化疗联合靶向或免疫治疗的精准疗法，可以显著延长转移性三阴性乳腺癌患者生存期。
该研究在我国多家知名医疗机构开展，研究人员对转移性三阴性乳腺癌患者进行了化疗联合靶向或免疫治疗的精准疗法。结果显示，与传统治疗手段相比，新疗法不仅能显著延长患者的生存期，还能提高治疗效果，降低副作用。
据悉，该疗法通过对患者肿瘤基因的精准分析，为患者量身定制个体化治疗方案。研究人员表示，这一精准治疗“组合拳”在疗效和安全性方面均表现出优势，为三阴性乳腺癌患者带来了新的希望。
英文翻译：
News Title: New Therapy for “Most Toxic Breast Cancer” Shows Promising Results
Keywords: Breast cancer, New therapy, Precision treatment
News Content:
SHANGHAI, January 9 (Xinhua) — Triple-negative breast cancer is known as the “most toxic” due to its high malignancy, easy recurrence and metastasis, limited treatment options, and lack of effective targets. A clinical study on the first-line treatment of metastatic triple-negative breast cancer revealed that a precision therapy combining chemotherapy with targeted or immunotherapy can significantly prolong the survival of patients.
The study was conducted by several renowned medical institutions in China. Researchers administered a precision therapy combining chemotherapy with targeted or immunotherapy to patients with metastatic triple-negative breast cancer. The results showed that compared with conventional treatments, the new therapy can not only significantly extend survival but also improve efficacy and reduce adverse effects.
It is reported that the therapy involves precise analysis of the tumor genes of patients, allowing for tailored individualized treatment plans. Researchers pointed out that the precision “combination punch” has advantages in both efficacy and safety, bringing new hope for patients with triple-negative breast cancer.
【来源】http://www.chinanews.com/life/2024/01-09/10142860.shtml
Views: 1